Amgen AMGN Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $7.71B+88.5% | $4.09B-39.1% | $6.72B+2.5% | $6.55B+11.2% | ||
| $5.17B-7.6% | $5.59B+37.4% | $4.07B+19.1% | $3.42B+0.6% | ||
| $494M-6.8% | $530M+23.0% | $431M+7.5% | $401M+17.6% | ||
| $9.96B-13.3% | $11.49B+35.6% | $8.47B-12.9% | $9.72B+5.0% | ||
| $1.86B+69.5% | $1.1B-1.4% | $1.11B+18.8% | $936M+6.4% | ||
| -$1.94B-85.8% | -$1.05B— | —— | -$6.04B— | ||
| $5.12B+6.0% | $4.83B+6.1% | $4.56B+8.6% | $4.2B+4.6% | ||
| —— | $0-100% | $27.8B+301% | $6.94B+40.3% | ||
| $5B+38.9% | $3.6B— | —— | $0-100% | ||
| -$10.86B-15.3% | -$9.42B— | —— | —— | ||
| —— | $1.03B— | —— | -$360M— | ||
| $8.1B-22.1% | $10.39B+41.2% | $7.36B-16.2% | $8.79B+4.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Amgen generate?
- Amgen (AMGN) generated $10.8B in operating cash flow over the trailing twelve months.
- What is Amgen's free cash flow?
- After $2.2B of capital expenditures, Amgen's free cash flow was $8.6B over the trailing twelve months, down 21.2% year over year.
- Where does Amgen's cash flow data come from?
- Every line is extracted from Amgen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
